Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Purpose of This Study is to Monitor Fracture Risk Associated With Bone Tumors in Cancer Patients

NCT02109952 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT02109952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02109952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Purpose of This Study is to Monitor Fracture Risk Associated With Bone Tumors in Cancer Patients
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2009
Completion date
December 31, 2025
Enrollment
245 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

bone tumors, cancer bone